ArticlePakistan journal of medical sciences2026
Development and validation of a nomogram for predicting recurrence in epithelial ovarian cancer after primary cytoreductive surgery: A single-center retrospective study.
Article in Pakistan journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore the risk factors for recurrence of epithelial ovarian cancer (EOC) after primary cytoreductive surgery, and to develop and validate a risk prediction model based on the identified factors. Methodology: Clinical data of 213 patients with epithelial ovarian cancer (EOC) who underwent primary cytoreductive surgery (CRS) in Huzhou Maternity & Child Health Care Hospital, China from January 2020 to July 2025 were retrospectively collected. Patients were randomly divided into a training (n=128) and a validation cohort (n=85) at a ratio of 6:4. The Least Absolute Shrinkage and Selection Operator (LASSO) regression and multivariable logistic regression were utilized for feature selection in the training cohort to construct a nomogram for predicting postoperative recurrence. The discriminative performance and calibration of the nomogram were evaluated in both cohorts utilizing the area under the receiver operating characteristic curve (AUC) and the Hosmer-Lemeshow test. Results: The EOC recurrence rate was 40.8% (87/213). The analysis identified six independent risk factors for predicting recurrence, including International Federation of Gynecology and Obstetrics (FIGO) stage, differentiation grade, residual lesions, positive ascites cytology, carbohydrate antigen 125 (CA125) positive, and positive Risk of Ovarian Malignancy Algorithm (ROMA) index. The nomogram model demonstrated sufficient predictive accuracy, with AUC values of 0.861 (95%CI: 0.795-0.928) and 0.801 (95%CI: 0.697-0.904) in the training and validation cohorts, respectively. The results of the H-L test showed good fitness. Conclusions: The nomogram model developed in this study exhibits good predictive performance and applicability, and can be used to screen for the risk of recurrence in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.